Enhancing the utility of polygenic scores in Alzheimer's disease through systematic curation and annotation

被引:0
|
作者
Mwesigwa, Savannah [1 ]
Dai, Yulin [1 ]
Enduru, Nitesh [1 ]
Zhao, Zhongming [1 ,2 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Ctr Precis Hlth, McWilliams Sch Biomed Informat, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Faillace Dept Psychiat & Behav Sci, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; genetic variant; PGS catalog; polygenic scores; rank aggregation; RISK; MODELS;
D O I
10.3389/fgene.2025.1507395
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction Polygenic Scores (PGSs) assess cumulative genetic risk variants that contribute to the association with complex diseases like Alzheimer's Disease (AD). The PGS Catalog is a valuable repository of PGSs of various complex diseases, but it lacks standardized annotations and harmonization, making the information difficult to integrate for a specific disease.Methods In this study, we curated 44 PGS datasets for AD from the PGS Catalog, categorized them into five methodological groups, and annotated 813,257 variants to nearby genes. We aligned the scores based on the "GWAS significant variants" (GWAS-SV) method with the GWAS Catalog and flagged redundant files and those with a "limited scope" due to insufficient external GWAS support. Using rank aggregation (RA), we prioritized consistently important variants and provided an R package, "PgsRankRnnotatR," to automate this process.Results Of the six RA methods evaluated, "Dowdall" method was the most robust. Our refined dataset, enhanced by multiple RA options, is a valuable resource for AD researchers selecting PGSs or exploring AD-related genetic variants.Discussion Our approach offers a framework for curating, harmonizing, and prioritizing PGS datasets, improving their usability for AD research. By integrating multiple RA methods and automating the process, we provide a flexible tool that enhances PGS selection and genetic variant exploration. This framework can be extended to other complex diseases or traits, facilitating broader applications in genetic risk assessment.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Alzheimer's disease as a polygenic disease
    Okuizumi, K
    Tsuji, S
    NEUROPATHOLOGY, 1998, 18 (01) : 111 - 115
  • [22] Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease
    Hyun-Sik Yang
    Ling Teng
    Daniel Kang
    Vilas Menon
    Tian Ge
    Hilary K. Finucane
    Aaron P. Schultz
    Michael Properzi
    Hans-Ulrich Klein
    Lori B. Chibnik
    Julie A. Schneider
    David A. Bennett
    Timothy J. Hohman
    Richard P. Mayeux
    Keith A. Johnson
    Philip L. De Jager
    Reisa A. Sperling
    Nature Communications, 14
  • [23] Identifying individuals with high risk of Alzheimer's disease using polygenic risk scores
    Leonenko, Ganna
    Baker, Emily
    Stevenson-Hoare, Joshua
    Sierksma, Annerieke
    Fiers, Mark
    Williams, Julie
    de Strooper, Bart
    Escott-Price, Valentina
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [24] Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
    Ganna Leonenko
    Emily Baker
    Joshua Stevenson-Hoare
    Annerieke Sierksma
    Mark Fiers
    Julie Williams
    Bart de Strooper
    Valentina Escott-Price
    Nature Communications, 12
  • [25] Clinical utility of polygenic risk scores for coronary artery disease
    Derek Klarin
    Pradeep Natarajan
    Nature Reviews Cardiology, 2022, 19 : 291 - 301
  • [26] Polygenic Risk Scores in Alzheimer's Disease Genetics: Methodology, Applications, Inclusion, and Diversity
    Clark, Kaylyn
    Leung, Yuk Yee
    Lee, Wan-Ping
    Voight, Benjamin
    Wang, Li-San
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 89 (01) : 1 - 12
  • [27] Clinical utility of polygenic risk scores for coronary artery disease
    Klarin, Derek
    Natarajan, Pradeep
    NATURE REVIEWS CARDIOLOGY, 2021, 19 (5) : 291 - 301
  • [28] Association of whole-person eigen-polygenic risk scores with Alzheimer's disease
    Kharaghani, Amin
    Tio, Earvin S.
    Milic, Milos
    Bennett, David A.
    De Jager, Philip L.
    Schneider, Julie A.
    Sun, Lei
    Felsky, Daniel
    HUMAN MOLECULAR GENETICS, 2024, 33 (15) : 1315 - 1327
  • [29] Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer's disease
    Leffa, Douglas T.
    Povala, Guilherme
    Bellaver, Bruna
    Ferrari-Souza, Joao Pedro
    Ferreira, Pamela C. L.
    Lussier, Firoza Z.
    Aguzzoli, Cristiano Schaffer
    Soares, Carolina
    Zalzale, Hussein
    Rohden, Francieli
    Bauer-Negrini, Guilherme
    Abbas, Sarah
    Schneider, Maite
    Therriault, Joseph
    Lopez, Oscar L.
    Villemagne, Victor L.
    Klunk, William E.
    Tudorascu, Dana L.
    Cohen, Ann D.
    Rosa-Neto, Pedro
    Zimmer, Eduardo R.
    Karikari, Thomas K.
    Rohde, Luis Augusto
    Molina, Brooke S. G.
    Pascoal, Tharick A.
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [30] Polygenic scores and Mendelian randomization identify plasma proteins causally implicated in Alzheimer's disease
    Cammann, Davis B.
    Lu, Yimei
    Rotter, Jerome I.
    Wood, Alexis C.
    Chen, Jingchun
    FRONTIERS IN NEUROSCIENCE, 2024, 18